Other ways to search: Events Calendar | UTHSC

Simple biomarkers offer early warning of hidden heart risk in childhood cancer survivors


Data from the St. Jude lifetime cohort study (St. Jude LIFE) revealed that two common biomarkers of cardiac function and damage could better predict cardiomyopathy within five years than routine clinical evaluations in high-risk, asymptomatic childhood cancer survivors. Early detection through screening using these two biomarkers may lead to earlier treatment to prevent and protect against further heart damage. The findings were published today in the Journal of Clinical Oncology.

Top Publishers